Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
651 A phase 1, multicenter, open-label, dose-escalation, safety, pharmacodynamic, pharmacokinetic study of Q702 with a cohort expansion at the RP2D in patients with advanced solid tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.
